<SEC-DOCUMENT>0001829126-24-004116.txt : 20240726
<SEC-HEADER>0001829126-24-004116.hdr.sgml : 20240726
<ACCEPTANCE-DATETIME>20240612152155
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001829126-24-004116
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240612

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nexalin Technology, Inc.
		CENTRAL INDEX KEY:			0001527352
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				275566468
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1776 YORKTOWN
		STREET 2:		SUITE 550
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
		BUSINESS PHONE:		(832) 260-0222

	MAIL ADDRESS:	
		STREET 1:		1776 YORKTOWN
		STREET 2:		SUITE 550
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77056
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 75%; text-indent: 0pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARSHAW
                                            BURSTEIN, LLP</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">575
    Lexington Avenue</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, NY 10022</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
    212-984-7700</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.wbny.com</FONT></P></TD>
    <TD STYLE="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: right; text-indent: 0pt"><IMG SRC="img_001.jpg" ALT=""></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
12, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIA
EDGAR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Industrial Applications and Services</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Mr. Robert Augustin</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ms.
Jane Park</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nexalin
Technology, Inc.</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
Statement on Form S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
May 23, 2024</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
No. 333-279684</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of our client, Nexalin Technology, Inc., a Delaware corporation (the &ldquo;<B><U>Company</U></B>&rdquo;), we are writing to submit
the Company&rsquo;s response to the comment of the staff (the &ldquo;<B><U>Staff</U></B>&rdquo;) of the Division of Corporation Finance
of the United States Securities and Exchange Commission (the &ldquo;<B><U>SEC</U></B>&rdquo;) with respect to the above-referenced Registration
Statement on Form S-1 filed on May 23, 2024 (File No. 333-279684, the &ldquo;<B><U>Registration Statement</U></B>&rdquo;), contained
in the Staff&rsquo;s letter dated June 5, 2024 (the &ldquo;<B><U>Comment Letter</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
ease of reference, the comment contained in the Comment Letter is printed below in bold and is followed by the Company&rsquo;s response.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Registration
Statement on Form S-1</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&nbsp;We note your disclosure on page 4 relating to your joint venture established for the clinical development, marketing, sale and
distribution of your second generation transcranial Alternating Current Stimulation devices in China and other countries in the
region. Additionally, we note your disclosure in your Form 10-Q for the quarterly period ended March 31, 2024 that you
&ldquo;receive revenue from the sale in China of our Devices to [y]our distributor and from the sale of products relating to the use
of those Devices&rdquo; and &ldquo;derive revenue as a royalty fee from the China-based manufacturer for electrodes ordered in
connection with [y]our China sales.&rdquo; To the extent you do not conduct the majority of your operations in China, please provide
us your analysis supporting this. To the extent you conduct the majority of your operations in China, please revise your filing, as
applicable, to provide more specific and prominent disclosures about the legal and operational risks associated with China-based
companies. For additional guidance, please see the Division of Corporation Finance&rsquo;s Sample Letter to China-Based Companies
issued by the Staff in December 2021 and the Sample Letter to Companies Regarding China-Specific Disclosures issued by the Staff in
July 2023.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><B>WARSHAW BURSTEIN, LLP</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Division of Corporation Finance - Office of Industrial Applications and
Services</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">June 12, 2024</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Page 2</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
The Company respectfully advises the Staff that the Company does not conduct the majority of its operations in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a Delaware corporation with its business headquarters and a warehouse located in Houston, Texas. All members of the Company&rsquo;s
management team are located in the United States. The Company&rsquo;s President and Chief Executive Officer, Mark White, conducts his
business operations through the Company&rsquo;s headquarters in Texas. Dr. David Owens, the Company&rsquo;s Chief Medical Officer, operates
from Georgia; Michael Nketiah, the Company&rsquo;s Senior Vice President of Quality, Regulatory and Clinical Affairs, operates from California;
and Marilyn Elson, the Company&rsquo;s Controller, operates from New Jersey. The Company&rsquo;s financial services team is located in
Arizona, and the Company utilizes manufacturing facilities, and research and development consultants, located in California. All members
of the Company&rsquo;s board of directors reside in the United States. The Company has no employees or office in China and none of the
Company&rsquo;s operations are conducted in China.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
personnel located in the United States oversee all clinical protocol development for Food and Drug Administration submissions and clinical
trial investigations for future treatment indications (which regulatory clearance submissions are discussed beginning on page 7 of the
Registration Statement). Clinical and pilot testing of the Company&rsquo;s devices is conducted both in the United States and in China.
However, all activity in China is conducted by and through the Company&rsquo;s Hong Kong-registered joint venture with Wider Come Limited
(as described in more detail beginning on page 7 of the Registration Statement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s revenue is derived from the sale of devices and equipment, as well as related licensing fees. During the 2023 fiscal
year, 96.7% of the Company&rsquo;s revenue was derived from sales in the United States, with the remaining 3.3% of revenues being attributable
to China-based sources. For the first fiscal quarter of 2024, 70.5% of the Company&rsquo;s revenue was derived from sales in Oman, and
29.5% of the quarterly revenue came from U.S. sales (with no revenue from China). The Company may derive additional revenue from China
in the future as a result of sales of devices and equipment and the receipt of licensing fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
do not hesitate to contact Martin Siegel, of Warshaw Burstein, LLP, at (212) 984-7741 with any questions or comments regarding this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Best
    regards,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Warshaw Burstein, LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nexalin
    Technology, Inc.</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    White, President and Chief Executive Officer</FONT></TD>
    <TD STYLE="padding: 0pt; line-height: 107%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.75pt"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32.75pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>img_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "2 )(# 2(  A$! Q$!_\0
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MNGW%C#>3QV=P09K=3A)/]X9YKJ/^%R>,/^@N/_ 6'_XBC_A<GC#_ *"P_P#
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M.!7C&U6ZKFEP!P!@5,I71+Q,G3]FU8]A^'GCK1=%_9Y^)_AV]O6BU?5C"UI
M!DRX;D"O,?"=]!HWBK1+V[(CM;:\BEEPN_Y0P)-9=+QW&:A&7MW)KR/KSXH>
M(?!OCSQYJNOV'[0.L:'::@R@:;!'*8HE"@$!0<<UXA\.=4T+X=?M":'J#:V^
MIZ#IVH>;)JICX=3_ !!>YKS+:O\ < _"D\LUKSG34QDZTE/EV/6K'QIHJ_M5
M+XK>Z4>'SK_V_P"T[#PA[X]*S=2^+%]X0^.GB#QIX0OF*R:E)/$S)M2YA)^9
M77^(,.U>;TM+VAG'$SA\)[+^U!\6-)^,NN^%M9TB#[$L6F""YL\8%O*&RRCV
MYX->-8"J!_GK114-W=S"<I5).;W84445)G9A1110&H4444!=A1110%V%%%%
M:A1110/4**** "BBB@5V%%%% :A1110&H4444!J%%%% ^8**** Y@HHHH#F"
MBBB@.8**** Y@HHHH"X4444!S!1110',%%%% <P4444!S!1110(**** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
